News

Nature’s Sunshine Products, Inc. (NATR) Q4 2024 Earnings Call Transcript

1 Mins read

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q4 2024 Results Conference Call March 11, 2025 5:00 PM ET

Company Participants

Nate Brower – General Counsel
Terrence Moorehead – Chief Executive Officer
Shane Jones – Chief Financial Officer

Conference Call Participants

Susan Anderson – Canaccord
Linda Bolton-Weiser – D.A. Davidson

Operator

Good afternoon, everyone, and thank you for participating in today’s conference call to discuss Nature’s Sunshine’s Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024. Joining us today are Nature’s Sunshine’s CEO, Terrence Moorehead; CFO, Shane Jones; and General Counsel, Nate Brower. Following their remarks, we’ll open the call for analyst questions.

Before we go further, I would like to turn the call over to Mr. Brower as he reads the Company’s safe harbor statement within the meaning of the Private Securities Litigation Reform Act of 1995 that provides important cautions regarding forward-looking statements.

Nate, please go ahead.

Nate Brower

Good afternoon, and thanks for joining our conference call to discuss our fourth quarter and full year 2024 financial results. I’d like to remind everyone that this call is available for replay via telephonic dial-in through March 25 and via a live webcast that will be posted on the Investor Relations portion of our website at ir.naturessunshine.com.

The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements.

Factors that could cause results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the Company’s annual report on Form 10-K under the caption Risk Factors and other reports filed with the Securities and Exchange

Read the full article here

Related posts
News

Philip Morris Stock Appears Overvalued Compared To Peers (NYSE:PM)

1 Mins read
This article was written by Follow Philipp is a seasoned value investor with nearly 20 years of experience in the field. He…
News

Imperial Brands: Resilient Market Performance And A Strong Cash Flow Yield (OTCMKTS:IMBBY)

1 Mins read
This article was written by Follow I have more than five years experience in the financial industry. I focus mostly in the…
News

Oncolytics Biotech Stock: Continuing To Justify The Negativity (NASDAQ:ONCY)

1 Mins read
This article was written by Follow I have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *